A well-drafted Investment Representation Agreement reduces dispute risk, clarifies investor reliance, and supports regulatory compliance. It helps parties identify material facts, allocate responsibility for inaccuracies, and define remedies, improving certainty during closing and after funding.
Common users include corporate issuers, accredited investors, placement agents, and legal counsel involved in private and public financing transactions.
Each party should confirm capacity, authority, and relevant state law prior to execution to avoid enforceability issues.
The issuer's CEO or CFO signs after board authorization and represents corporate authority, capitalization, and disclosure accuracy. Legal counsel reviews representations to align with securities laws and to limit ongoing disclosure obligations and indemnity exposure.
An accredited investor signs to confirm status, acknowledge reliance on representations, and accept investment terms. Investor counsel often negotiates survival periods, carve-outs for known exceptions, and documentation required for accreditation verification.
State factual assertions about business condition, capitalization, material contracts, compliance with law, and pending disputes. Precise language and defined materiality thresholds limit ambiguity and set boundaries for investor reliance and remedies.
Provide contractual promises regarding ownership of assets, authority to enter the transaction, and accuracy of financial statements. Warranties often survive closing for negotiated periods and underpin indemnity obligations if breached.
Attach detailed schedules that qualify or carve out exceptions to representations and warranties. Well-structured schedules reduce disputes by cataloging known issues and provide a mechanism for updating disclosures during diligence.
Specify the scope, limitations, caps, and baskets for indemnification. Clear indemnity language determines who bears loss from breaches, third-party claims, and tax liabilities post-closing and often interacts with escrow arrangements.
Define how long representations and warranties remain actionable after closing; include exceptions for fraud or fundamental representations. Short survival periods limit post-closing exposure but may reduce investor recourse.
Confirm corporate authorization, necessary approvals, and signatory names and titles. Include board resolutions or power-of-attorney references to validate authority and prevent later challenges to execution or enforceability.
| Workflow Field / Configuration Heading | Configuration options for each workflow field |
|---|---|
| Signer Authentication Method and Strength | Email, SMS code, KBA, or SSO |
| Signature Order and Role Assignments | Sequential or parallel signing with role mapping |
| Field Types and Validation Rules | Signature, initial, date, checkbox, conditional field |
| Record Retention and Archive Settings | PDF storage, audit trail, export to cloud |
For digital execution, verify integrations, supported file formats, and authentication options with your eSignature provider.
Effective date governs obligations and limitation periods.
Provide payer information promptly to meet IRS reporting deadlines.
Verify accreditation before acceptance; retain supporting documents per IRS/SEC guidance.
Confirm negotiated survival durations and caps to limit post-closing liability.
Retention typically begins at execution; check industry-specific rules for alternate triggers.
Finalize statements, schedules, and exhibits for internal approval.
Counsel verifies representations, regulatory compliance, and negotiation points.
All parties sign, apply authentication, and collect notarizations if required.
Distribute executed copies, fund transfers, and update cap table records.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | Yes, 7-day free trial | No | No | Yes, limited | Yes, limited |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
A startup negotiates representations covering IP, capitalization, and material contracts to close a Series A financing.
A sponsor offers a private placement to a family office with customized tax and transfer restrictions.